These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
625 related items for PubMed ID: 7558090
1. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia. Gambhir DS, Bhargava M, Arora R, Khalilullah M. Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090 [Abstract] [Full Text] [Related]
2. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia]. Musto B, D'Onofrio A, Cavallaro C, Musto A, Della Gatta O, Marsico F. G Ital Cardiol; 1987 May; 17(5):444-9. PubMed ID: 3115857 [Abstract] [Full Text] [Related]
3. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination]. Purcaro A, Capestro F, Ciampani N, Fratadocchi GB, Mazzanti M, Costantini C, Molini E. G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426 [Abstract] [Full Text] [Related]
4. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia. Gambhir DS, Bhargava M, Nair M, Arora R, Khalilullah M. Indian Heart J; 1996 Aug; 48(2):133-7. PubMed ID: 8682552 [Abstract] [Full Text] [Related]
5. [Electrophysiologic effects of intravenous flecainide in intranodal junctional tachycardia in 30 patients]. Haissaguerre M, Warin JF, Goldrach S, Le Métayer P, Guillem JP, Blanchot P. Arch Mal Coeur Vaiss; 1988 Dec; 81(12):1493-8. PubMed ID: 3147639 [Abstract] [Full Text] [Related]
6. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway]. Fauchier JP, Cosnay P, Rouesnel P, Moquet B, Bonnet P, Scala PJ, Demeyer JF. Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264 [Abstract] [Full Text] [Related]
7. [Role of a "bystander" concealed accessory pathway in the response to verapamil and flecainide treatment in a patient with nodal reentry tachycardia]. Matteucci C, Busi G. G Ital Cardiol; 1996 Apr; 26(4):419-25. PubMed ID: 8707026 [Abstract] [Full Text] [Related]
8. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia]. Pfitzner P, Manz M, Schütz R, Lüderitz B. Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252 [Abstract] [Full Text] [Related]
9. Comparative clinical and electrophysiologic effects of adenosine and verapamil on termination of paroxysmal supraventricular tachycardia. Sethi KK, Singh B, Kalra GS, Arora R, Khalilullah M. Indian Heart J; 1994 Oct; 46(3):141-4. PubMed ID: 7821934 [Abstract] [Full Text] [Related]
10. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia]. Brandão L, de Sousa J, Barreiros MC, Vagueiro MC, Amram SS. Rev Port Cardiol; 1994 Mar; 13(3):197-202, 191. PubMed ID: 8049086 [Abstract] [Full Text] [Related]
11. [Effects of intravenous flecainide acetate in patients with concealed atrioventricular pathway with supraventricular tachycardia]. Song Y. Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):361-3, 397. PubMed ID: 1821351 [Abstract] [Full Text] [Related]
12. [Electrophysiologic effects and clinical efficacy of propafenone in pediatric patients with paroxysmal supraventricular reentrant tachycardia]. Musto B, D'Onofrio A, Musto A, Cavallaro C, Marsico F. G Ital Cardiol; 1986 Apr; 16(4):336-43. PubMed ID: 3743937 [Abstract] [Full Text] [Related]
13. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias. Fujiki A, Tani M, Mizumaki K, Shimono M, Inoue H. J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979 [Abstract] [Full Text] [Related]
14. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia. Hoff PI, Tronstad A, Oie B, Ohm OJ. Am J Cardiol; 1988 Sep 15; 62(9):585-9. PubMed ID: 3137798 [Abstract] [Full Text] [Related]
15. [Usefulness of transesophageal electrophysiological study during the ergometric test in the evaluation of supraventricular paroxysmal tachycardia occurring during exertion]. Delise P, D'Este D, Bonso A, Allibardi P, Raviele A, Di Pede F, Piccolo E. G Ital Cardiol; 1989 Dec 15; 19(12):1094-104. PubMed ID: 2576799 [Abstract] [Full Text] [Related]
16. [The pharmacological treatment of supraventricular atrioventricular nodal reentry or accessory pathway reentry tachycardias: the usefulness of transesophageal electrophysiological study in the selection of therapy]. Sarubbi B, Ducceschi V, Esposito R, Briglia N, Manzo G, Mayer MS, Santangelo L, Iacono A. Cardiologia; 1996 Jun 15; 41(6):543-9. PubMed ID: 8766417 [Abstract] [Full Text] [Related]
17. Unusual induction of slow-fast atrioventricular nodal reentrant tachycardia. Report of two cases. Calò L, Riccardi R, Scaglione M, Caponi D, Golia P, Gaita F. G Ital Cardiol; 1999 Nov 15; 29(11):1318-22. PubMed ID: 10609133 [Abstract] [Full Text] [Related]
18. [Exogenous adenosine as an anti-arrhythmia agent]. Tebbenjohanns J, Pfeiffer D, Schumacher B, Korte T, Jung W, Lüderitz B. Z Kardiol; 1996 Nov 15; 85 Suppl 6():191-9. PubMed ID: 9064965 [Abstract] [Full Text] [Related]
19. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias. Hellestrand KJ, Nathan AW, Bexton RS, Spurrell RA, Camm AJ. Am J Cardiol; 1983 Mar 01; 51(5):770-6. PubMed ID: 6829436 [Abstract] [Full Text] [Related]
20. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia. Musto B, D'Onofrio A, Cavallaro C, Musto A, Greco R. Am J Cardiol; 1988 Aug 01; 62(4):229-33. PubMed ID: 3135739 [Abstract] [Full Text] [Related] Page: [Next] [New Search]